0
0
12/8/23 at 11:27pm
Organization
Ars Technica
Author
Beth Mole
26 words
0
Comments
The landmark treatment turns on another blood protein that prevents sickling.
You are the first to view
https://arstechnica.com/science/2023/12/heres-how-the-first-fda-approved-crispr-therapy-works-to-treat-sickle-cell/
Create an account
or login to join the discussion